The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.

PHYSICIAN PERSPECTIVE - Viewpoint based on literature review

Options for Extending Survival in Advanced Colorectal Cancer: Increasing Evidence for a Chronic Therapy Approach

December 2012

Reviewed and Edited by:Sharlene Gill, MD, MPH, FACP, FRCPCGastrointestinal Medical OncologistBC Cancer AgencyAssociate Professor of MedicineUniversity of British ColumbiaVancouver, British Columbia Introduction Monoclonal antibodies...

PRIORITY PRESS - 54th Annual Meeting of the American Society of Hematology

Seeking Better Outcomes for Indolent Lymphomas

Atlanta, Georgia / December 8-11, 2012

Atlanta - Decades of laboratory and clinical research have yet to determine the optimal therapy for indolent non-Hodgkin lymphoma and mantle-cell lymphoma. The combination of cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP)...

PRIORITY PRESS - 54th Annual Meeting of the American Society of Hematology

Improving Overall Survival in Multiple Myeloma: Treatment Strategies and Regimens

Atlanta, Georgia / December 8-11, 2012

Atlanta - New data released at the 2012 American Society of Hematology (ASH) meeting further linked novel combinations with improved survival across multiple stages of multiple myeloma (MM). Given the relapsing/remitting nature of the...

PRIORITY PRESS - 2012 CTRC-AACR San Antonio Breast Cancer Symposium

Better Survival with Endocrine Therapy for Metastatic Breast Cancer

San Antonio, Texas / December 4-8, 2012

San Antonio - Metastatic progression or recurrence of advanced breast cancer (BC) remains essentially an incurable disease. In the absence of curative therapy, interventions that extend survival and/or maintain quality of life have...

PRIORITY PRESS - 63rd McGill Annual Refresher Course for Family Physicians

Update on Family Medicine: Oral Anticoagulants, Stroke Management, Ovarian Cancer

Montréal, Quebec / November 26-28, 2012

Montreal - At this year’s McGill Refresher Course, delegates heard about potentially practice-altering patient management strategies for common conditions. In a plenary session, they were informed about using dabigatran, rivaroxaban...

PRIORITY PRESS - 4th European Multidisciplinary Meeting on Urological Cancers (EMUC 2012)

Targeting the Androgen Receptor in Castrate-resistant Prostate Cancer: A Step Forward

Barcelona, Spain / November 16-18, 2012

Barcelona - In prostate cancer, medical or surgical androgen ablation therapy leads to tumour regression and a rapid decline in prostate-specific antigen (PSA). However, progression of the cancer despite castrate levels of testosterone is a...

PRIORITY PRESS - 37th European Society of Medical Oncology Congress (ESMO)

Exploring Benefits of Multitargeted Therapy for Metastatic Colorectal Cancer and Gastrointestinal Stromal Tumours

Vienna, Austria / September 28 – October 2, 2012

Vienna - Progress continues to occur in the treatment of metastatic colorectal cancer. Improved recognition of the complexities of tumour signalling networks have led to the realization that inhibition of a single pathway is unlikely to...

PRIORITY PRESS - 21st Congress of the European Academy of Dermatology and Venereology (EADV)

Progress in Advanced Basal-cell Carcinoma: Exploring Hedgehog Pathway Inhibition

Prague, Czech Republic / September 27-30, 2012

Prague - Basal-cell carcinoma (BCC) is the most commonly diagnosed human cancer worldwide. Most BCCs are readily treated by surgery, but some lesions progress to an advanced state (locally advanced BCC) or spread to distant sites...


Managing Inequities in Protection Against HPV-related Disease Through Gender-neutral Vaccination

Prague, Czech Republic / July 8-11, 2012

Prague - When routine vaccination against the human papillomavirus (HPV) was first approved in 2006, it was focused on preventing cervical cancer in women. However, a range of cancers is now known to be associated with HPV in men and women,...

PAGE 3 OF 23   1 2 3 4 5 6 7 8 9 10 ...